HealthCare Global Enterprises Crecimiento futuro
Future controles de criterios 4/6
Se prevé un crecimiento anual de los beneficios y los ingresos de HealthCare Global Enterprises de 62.5% y 12.1% por año respectivamente. Se prevé que el BPA crezca en un 64.2% al año. Se espera que la rentabilidad financiera sea de 10.7% en 3 años.
Información clave
62.5%
Tasa de crecimiento de los beneficios
64.2%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare | 26.3% |
| Tasa de crecimiento de los ingresos | 12.1% |
| Rentabilidad financiera futura | 10.7% |
| Cobertura de analistas | Good |
| Última actualización | 15 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
HealthCare Global Enterprises Limited Just Missed EPS By 79%: Here's What Analysts Think Will Happen Next
Feb 11
We Think Shareholders Will Probably Be Generous With HealthCare Global Enterprises Limited's (NSE:HCG) CEO Compensation
Sep 14A Look At The Fair Value Of HealthCare Global Enterprises Limited (NSE:HCG)
Sep 05HealthCare Global Enterprises Limited's (NSE:HCG) Business Is Yet to Catch Up With Its Share Price
May 17Does HealthCare Global Enterprises (NSE:HCG) Have A Healthy Balance Sheet?
Jun 24Shareholders Shouldn’t Be Too Comfortable With HealthCare Global Enterprises' (NSE:HCG) Strong Earnings
Jun 03Is HealthCare Global Enterprises (NSE:HCG) Using Too Much Debt?
Dec 08What Does HealthCare Global Enterprises Limited's (NSE:HCG) Share Price Indicate?
Jun 25Insider Buying: The HealthCare Global Enterprises Limited (NSE:HCG) Executive Chairman Just Bought ₹2.4m Worth Of Shares
Mar 14The HealthCare Global Enterprises (NSE:HCG) Share Price Is Up 51% And Shareholders Are Holding On
Mar 03Here's Why HealthCare Global Enterprises (NSE:HCG) Can Afford Some Debt
Jan 27How Many HealthCare Global Enterprises Limited (NSE:HCG) Shares Did Insiders Buy, In The Last Year?
Dec 23
Reflecting on HealthCare Global Enterprises' (NSE:HCG) Share Price Returns Over The Last Three Years
Nov 10What Type Of Shareholders Own The Most Number of HealthCare Global Enterprises Limited (NSE:HCG) Shares?
Sep 18HealthCare Global Enterprises' (NSE:HCG) Shareholders Are Down 52% On Their Shares
Aug 07Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 3/31/2026 | 24,302 | 1,401 | 2,214 | N/A | 9 |
| 3/31/2025 | 21,730 | 928 | 1,798 | N/A | 9 |
| 3/31/2024 | 19,193 | 398 | 915 | N/A | 9 |
| 12/31/2023 | 18,592 | 353 | N/A | N/A | N/A |
| 9/30/2023 | 18,140 | 371 | 922 | 2,197 | N/A |
| 6/30/2023 | 17,471 | 309 | N/A | N/A | N/A |
| 3/31/2023 | 16,944 | 293 | 1,184 | 2,516 | N/A |
| 12/31/2022 | 16,174 | 270 | N/A | N/A | N/A |
| 9/30/2022 | 15,507 | -264 | 1,156 | 2,364 | N/A |
| 6/30/2022 | 14,827 | 694 | N/A | N/A | N/A |
| 3/31/2022 | 13,978 | 537 | 1,489 | 2,201 | N/A |
| 12/31/2021 | 13,312 | -544 | N/A | N/A | N/A |
| 9/30/2021 | 12,472 | -379 | 1,089 | 1,510 | N/A |
| 6/30/2021 | 11,431 | -1,633 | N/A | N/A | N/A |
| 3/31/2021 | 10,134 | -1,935 | 851 | 1,205 | N/A |
| 12/31/2020 | 9,858 | -1,349 | N/A | N/A | N/A |
| 9/30/2020 | 9,897 | -1,284 | 751 | 1,271 | N/A |
| 6/30/2020 | 10,202 | -1,284 | N/A | N/A | N/A |
| 3/31/2020 | 10,956 | -1,067 | 223 | 1,301 | N/A |
| 12/31/2019 | 10,832 | -718 | N/A | N/A | N/A |
| 9/30/2019 | 10,541 | -552 | N/A | N/A | N/A |
| 6/30/2019 | 10,210 | -394 | N/A | N/A | N/A |
| 3/31/2019 | 9,787 | -248 | -903 | 985 | N/A |
| 12/31/2018 | 9,430 | -135 | N/A | N/A | N/A |
| 9/30/2018 | 9,004 | -41 | N/A | N/A | N/A |
| 6/30/2018 | 8,661 | 124 | N/A | N/A | N/A |
| 3/31/2018 | 8,307 | 205 | -1,583 | 978 | N/A |
| 12/31/2017 | 7,909 | 257 | N/A | N/A | N/A |
| 9/30/2017 | 7,608 | 278 | N/A | N/A | N/A |
| 6/30/2017 | 7,237 | 219 | N/A | N/A | N/A |
| 3/31/2017 | 7,001 | 230 | N/A | 913 | N/A |
| 12/31/2016 | 6,705 | 208 | N/A | N/A | N/A |
| 9/30/2016 | 6,392 | 133 | N/A | N/A | N/A |
| 6/30/2016 | 6,081 | 67 | N/A | N/A | N/A |
| 3/31/2016 | 5,842 | -178 | N/A | 732 | N/A |
| 12/31/2015 | 5,611 | -33 | N/A | N/A | N/A |
| 9/30/2015 | 5,494 | 9 | N/A | 763 | N/A |
| 6/30/2015 | 5,323 | 9 | N/A | N/A | N/A |
| 3/31/2015 | 5,194 | 8 | N/A | 597 | N/A |
| 3/31/2014 | 4,513 | -356 | N/A | 514 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (62.5% al año) de HCG es superior a la tasa de ahorro (6.7%).
Beneficios vs. Mercado: Se prevé que los beneficios (62.5% al año) de HCG crezcan más rápidamente que el mercado Indian (18% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de HCG crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (12.1% al año) de HCG crezcan más rápidamente que los del mercado Indian (10.3% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 12.1% al año) de HCG crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de HCG sea baja dentro de 3 años (10.7%).